Autologous Human Mesenchymal Stem Cell-Based Therapy in Infertility: New Strategies and Future Perspectives
- PMID: 36671799
- PMCID: PMC9855776
- DOI: 10.3390/biology12010108
Autologous Human Mesenchymal Stem Cell-Based Therapy in Infertility: New Strategies and Future Perspectives
Abstract
Infertility could be associated with a few factors including problems with physical and mental health, hormonal imbalances, lifestyles, and genetic factors. Given that there is a concern about the rise of infertility globally, increased focus has been given to its treatment for the last several decades. Traditional assisted reproductive technology (ART) has been the prime option for many years in solving various cases of infertility; however, it contains significant risks and does not solve the fundamental problem of infertility such as genetic disorders. Attention toward the utilization of MSCs has been widely regarded as a promising option in the development of stem-cell-based infertility treatments. This narrative review briefly presents the challenges in the current ART treatment of infertility and the various potential applications of autologous MSCs in the treatment of these reproductive diseases.
Keywords: assisted reproductive technology; infertility; mesenchymal stem cells.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- World Health Organization. Infertility. [(accessed on 14 April 2022)]. Available online: https://www.who.int/health-topics/infertility#tab=tab_1.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
